Extensive sequence variation exists among isolates of murine cytomegalovirus within members of the m02 family of genes

Journal of General Virology

Volumn 88, Issue 3, 2007, Pages 758-769

  Corbett, Alexandra J ^a,b   Forbes, Catherine A ^a,b   Moro, Dorian ^c,d   Scalzo, Anthony A ^a,b  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b LIONS EYE INSTITUTE   (Australia)

^c EDITH COWAN UNIVERSITY   (Australia)

^d CHEVRON AUSTRALIA PTY LTD   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

M02 PROTEIN; SPACER DNA; UNCLASSIFIED DRUG; VIRUS DNA; VIRUS GLYCOPROTEIN;

ANIMAL CELL; ARTICLE; CELL SURFACE; CONTROLLED STUDY; CYTOMEGALOVIRUS; GENE DUPLICATION; GENE FUNCTION; GENE STRUCTURE; GENETIC CONSERVATION; GENETIC VARIABILITY; HOST CELL; MULTIGENE FAMILY; NONHUMAN; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; PRIORITY JOURNAL; PROTEIN BINDING; SEQUENCE ALIGNMENT; SEQUENCE ANALYSIS; STRAIN DIFFERENCE; TRANSCRIPTION REGULATION; VIRUS CELL INTERACTION; VIRUS GENOME; VIRUS ISOLATION; VIRUS STRAIN;

ANIMALS; BASE SEQUENCE; CERCOPITHECUS AETHIOPS; COS CELLS; DNA, VIRAL; FLOW CYTOMETRY; GENE EXPRESSION; GENES, VIRAL; MICE; MICROSCOPY, FLUORESCENCE; MOLECULAR SEQUENCE DATA; MUROMEGALOVIRUS; PHYLOGENY; POLYMORPHISM, GENETIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SEQUENCE HOMOLOGY, AMINO ACID; SYNTENY; VARIATION (GENETICS); VIRAL PROTEINS;

HUMAN HERPESVIRUS 5; MAIZE CHLOROTIC MOTTLE VIRUS; MURID HERPESVIRUS 1;

EID: 33847616209     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/vir.0.82623-0     Document Type: Article

References (47)

1. Alcami, A. & Koszinowski, U. H. (2000). Viral mechanisms of immune evasion. Immunol Today 21, 447-455.
2. Arase, H., Mocarski, E. S., Campbell, A. E., Hill, A. B. & Lanier, L. L. (2002). Direct recognition of cytomegalovirus by activating and inhibitory NK cell receptors. Science 296, 1323-1326.
3. Arav-Boger, R., Zong, J. C. & Foster, C. B. (2005). Loss of linkage disequilibrium and accelerated protein divergence in duplicated cytomegalovirus chemokine genes. Virus Genes 31, 65-72.
4. Bendtsen, J. D., Nielsen, H., von Heijne, G. & Brunak, S. (2004). Improved prediction of signal peptides: SignalP 3.0. J Mol Biol 340, 783-795.
5. Boname, J. M. & Chantler, J. K. (1992). Characterization of a strain of murine cytornegalovirus which fails to grow in the salivary glands of mice. J Gen Virol 73, 2021-2029.
6. Booth, T. W., Scalzo, A. A., Carrello, C., Lyons, P. A., Farrell, H. E., Singleton, G. R. & Shellam, G. R. (1993). Molecular and biological characterization of new strains of murine cytornegalovirus isolated from wild mice. Arch Virol 132, 209-220.
7. Brocchieri, L., Kiedal, T. N., Karlin, S. & Mocarski, E. S. (2005). Predicting coding potential from genome sequence: application to betaherpesviruses infecting rats and mice. J Virol 79, 7570-7596.
8. Brown, M. G., Dokun, A. O., Heusel, J. W., Smith, H. R., Beckman, D. L., Blattenberger, E. A., Dubbelde, C. E., Stone, L R., Scalzo, A. A. & Yokoyama, W. M. (2001). Vital involvement of a natural killer cell activation receptor in resistance to viral infection. Science 292, 934-937.
9. Bubic, I., Wagner, M., Krmpotic, A., Saulig, T., Kim, S., Yokoyama, W. M., Jonjic, S. & Koszinowski, U. H. (2004). Gain of virulence caused by loss of a gene in murine cytornegalovirus. J Virol 78, 7536-7544.
10. Chalmer, J. E., Mackenzie, J. S. & Stanley, N. F. (1977). Resistance to murine cytomegalovirus linked to the major histocompatibility complex of the mouse. J Gen Virol 37, 107-114.
11. Chee, M. S., Bankier, A. T., Beck S., Bohni, R., Brown, C. M., Cerny, R., Horsnell, T., Hutchison, C. A., III, Kouzarldes, T. & other authors (1990). Analysis of the protein-coding content of the sequence of human cytornegalovirus strain AD169. Curr Top Microbiol Immunol 154, 125-169.
12. Dambaugh, T. R. & Kieff, E (1982). Identification and nucleotide sequences of two similar tandem direct repeats in Epstein-Barr virus DNA. J Virol 44, 823-833.
13. Davis, C. L., Field, D., Metzger, D., Saiz, R., Morin, P. A., Smith, I. L., Spector, S. A. & Wills, C. (1999). Numerous length polymorphisms at short tandem repeats in human cytomegalovirus. J Virol 73, 6265-6270.
14. Ebeling, A., Kell, G. M., Knust, E. & Koszinowski, U. H. (1983). Molecular cloning and physical mapping of murine cytomegalovirus DNA. J Virol 47, 421-433.
15. Farrell, H. E. & Shellam, G. R. (1989). Immunoblot analysis of the antibody response to murine cytornegalovirus in genetically resistant and susceptible mice. J Gen Virol 70, 2573-2586.
16. French, A. R., Pingel, J. T., Wagner, M., Bubic, I., Yang, L., Kim, S., Koszinowski, U., Jonjic, S. & Yokoyama, W. M. (2004). Escape of mutant double-stranded DNA vir-us from innate immune control. Immunity 20, 747-756.
17. Frohman, M. A., Dush, M. K & Martin, G. R. (1988). Rapid production of full-length cDNAs from rare transcripts: amplification using a single gene-specific oligonucleotide primer. Proc Natl Acad Sci U S A 85, 8998-9002.
18. Hall, T. A. (1999). BioEdit: a user-friendly biological sequence alignment editor and analysis program for Windows 95/98/NT. Nucleic Acids Symp Ser 41, 95-98.
19. Hengel, H., Brune, W. & Koszinowski, U. H. (1998). Immune evasion by cytomegalovirus - survival strategies of a highly adapted opportunist. Trends Microbiol 6, 190-197.
20. Hengel, H., Reusch, U., Gutermann, A., Ziegler, H., Jonjic, S., Lucin, P. & Koszinowski, U. H. (1999). Cytomegaloviral control of MHC class I function in the mouse. Immunol Rev 168, 167-176.
21. Ho, M. (1991). Cytomegalovirus Biology and Infection, 2nd edn. New York: Plenum Medical Book Company.
22. Holtappels, R., Thomas, D., Podlech, J., Geginat G., Steffens, H.-P. & Reddehase, M. J. (2000a). The putative natural killer decoy early gene m04 (gp34) of murine cytomegalovirus encodes an antigenic peptide recognized by protective antiviral CD8 T cells. J Virol 74, 1871-1884.
23. d-restricted antigenic peptide encoded by murine cytornegalovirus early gene M84. J Gen Virol 81, 3037-3042.
24. Hudson, J. B., Walker, D. G. & Altamirano, M. (1988). Analysis in vitro of two biologically distinct strains of murine cytornegalovirus. Arch Virol 102, 289-295.
25. Kavanagh, D. G., Koszinowski, U. H. & Hill, A. B. (2001). The murine cytomegalovirus immune evasion protein m4/gp34 forms biochemically distinct complexes with class I MHC at the cell surface and in a pre-Golgi compartment. J Immunol 167, 3894-3902.
26. Kleijnen, M. F., Huppa, J. B., Lucin, P., Mukherjee, S., Farrell, H., Campbell, A. E., Koszinowski, U. H., Hill, A. B. & Ploegh, H. L. (1997). A mouse cytomegalovirus glycoprotein, gp34, forms a complex with folded class I MHC molecules in the ER which is not retained but is transported to the cell surface. EMBO J 16, 685-694.
27. Kozak M. (1986). Point mutations define a sequence flanking the AUG initiator codon that modulates translation by eukaryotic ribosomes. Cell 44, 283-292.
28. Lesniewski, M., Das, S., Skomorovska-Prokvolit, Y., Wang, F.-Z. & Pellett, P. E. (2006). Primate cytomegalovirus US12 gene family: a distinct and diverse clade of seven-transmembrane proteins. Virology 334, 286-298.
29. Lu, X., Kavanagh, D. G. & Hill, A. B. (2006). Cellular and molecular requirements for association of the murine cytomegalovirus protein m4/ gp34 with major histocompatibility complex class I molecules. J Virol 80, 6048-6055.
30. Lyons, P. A., Allan, J. E. Carrello, C., Shellam, G. R. & Scalzo, A. A. (1996). Effect of natural sequence variation at the H-2Ld-restricted CD8+ T cell epitope of the murine cytornegalovirus ie1-encoded pp89 on T cell recognition. J Gen Virol 77, 2615-2623.
31. Misra, V. & Hudson, J. B. (1980). Minor base sequence differences between the genomes of two strains of murine cytomegalovirus differing in virulence. Arch Virol 64, 1-8.
32. Nielsen, H. & Krogh, A. (1998). Prediction of signal peptides and signal anchors by a hidden Markov model. Proc Int Conf Intell Syst Mol Biol 6, 122-130.
33. Nielsen, H., Engelbrecht J., Brunak, S. & von Heijne, G. (1997). Identification of prokaryotic and eukaryotic signal peptides and prediction of their cleavage sites. Protein Eng 10, 1-6.
34. Oliveira, S. A., Park S.-H., Lee, P, Bendelac, A. & Shenk, T. E. (2002). Murine cytomegalovir-us m02 gene family protects against natural killer cell-mediated immune surveillance. J Virol 76, 885-894.
35. Pear, W. S., Miller, J. P., Xu, L, Pui, J. C., Soffer, B., Quackenbush, R. C., Pendergast A. M., Bronson, R., Aster, J. C. & other authors (1998). Efficient and rapid induction of a chronic myelogenous leukemia-like myeloproliferative disease in mice receiving P210 bcr/ ab1-transduced bone marrow. Blood 92, 3780-3792.
36. Pignatelli, S., Dal Monte, P., Rossini, G. & Landini, M. P. (2004). Genetic polymorphisms among human cytornegalovirus (HCMV) wild-type strains. Rev Med Virol 14, 383-410.
37. Rawlinson, W. D., Farrell, H. E. & Barrell, B. G. (1996). Analysis of the complete DNA sequence of murine cytomegalovirus. J Virol 70, 8833-8849.
38. Reusch, U., Muranyi, W., Lucin, P., Burgert, H. G., Hengel, H. & Koszinowski, U. H. (1999). A cytornegalovirus glycoprotein re-routes MHC class I complexes to lysosomes for degradation. EMBO J 18, 1081-1091.
39. Sahagun-Ruiz, A., Sierra-Honigmann, A. M., Krause, P. & Murphy, P. M. (2004). Simian cytornegalovirus encodes five rapidly evolving chemokine receptor homologues. Virus Genes 28, 71-83.
40. Scalzo, A. A., Fitzgerald, N. A., Simmons, A., La Vista, A. B. & Shellam, G. R. (1990). Cmv-1, a genetic locus that controls murine cytomegalovirus replication in the spleen. J Exp Med 171, 1469-1483.
41. Scalzo, A. A., Fitzgerald, N. A., Wallace, C. R., Gibbons, A. E., Smart Y. C., Burton, R. C. & Shellam, G. R. (1992). The effect of the Cmv-1 resistance gene, which is linked to the natural killer cell gene complex, is mediated by natural killer cells. J Immunol 149, 581-589.
42. Smith, H. R., Heusel, J. W, Mehta, 1. K, Kim, S., Domer, B. G., Naidenko, O. V, Iizuka, K, Furukawa, H., Beckman, D. L. & other authors (2002). Recognition of a virus-encoded ligand by a natural killer cell activation receptor. Proc Natl Acad Sci U S A 99, 8826-8831.
43. Smith, L. M., Shellam, G. R. & Redwood, A. J. (2006). Genes of murine cytomegalovirus exist as a number of distinct genotypes. Virology 352, 450-465.
44. Tusnady, G. E. & Simon, I. (1998). Principles governing amino acid composition of integral membrane proteins: apphcation to topology prediction. J Mol Biol 283, 489-506.
45. Tusnady, G. E. & Simon, I. (2001). The HMMTOP transmembrane topology prediction server. Bioinformatics 17, 849-850.
46. Voigt, V., Forbes, C. A., Tonkin, J. N., Degii-Esposti, M. A., Smith, H. R., Yokoyama, W. M. & Scalzo, A. A. (2003). Murine cytomegalovirus m157 mutation and variation leads to immune evasion of natural killer cells. Proc Natl Acad Sci U S A 100, 13483-13488.
47. Xu, J., Lyons, P. A., Carter, M. D., Booth, T. W., Davis-Poynter, N. J., Shellam, G. R. & Scalzo, A. A. (1996). Assessment of antigenicity and genetic variation of glycoprotein B of murine cytomegalovirus. J Gen Virol 77, 49-59.